Xiaoyong Xue
Donglu, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Si-Wu-Tang Targets Microbiota Homeostasis and Intestinal Mucosal Barriers to Provide Protection Against MASLD by Favoring P. goldsteinii-like Taxa Colonization.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 26, 2025
Bupleuri Radix Polysaccharides Alleviate MASLD by Regulating Muribaculaceae-Derived SCFAs in the Gut-Liver Axis.
Journal: International journal of molecular sciences
Published: November 24, 2025
Novel strategies for mitigating hepatic ischemia-reperfusion injury: targeting MICU1 and calcium-glycolytic homeostasis with acteoside.
Journal: International journal of biological sciences
Published: October 06, 2025
Mitochondrial damage-associated molecular patterns (mito-DAMPs): Determinants of hepatopathy progression and therapeutic implications.
Journal: Pharmacological research
Published: June 03, 2025
Aurantio-obtusin improves obesity and protects hepatic inflammation by rescuing mitochondrial damage in overwhelmed brown adipose tissue.
Journal: Chinese medicine
Published: January 11, 2025
Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 07, 2024
Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells.
Journal: Chinese medicine
Published: September 15, 2024
Senkyunolide A interrupts TRAF6-HDAC3 interaction to epigenetically suppress c-MYC and attenuate cholestatic liver injury.
Journal: Journal of advanced research
Published: July 23, 2024
Temporal-spatially metabolic reprogramming rewires the landscape of H3K27 acetylation to enable the initiation of liver regeneration.
Journal: Science bulletin
Published: July 12, 2024
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4.
Journal: Journal of hepatology
Published: July 09, 2024
Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice.
Journal: Chinese medicine
Published: March 19, 2024
Last Updated: 09/26/2026